SYNLAB agrees to sell its Spanish business to Eurofins

“As a result of a careful review of our portfolio and corresponding market developments in the diagnostics sector, we have decided to sell our Spanish operations to Eurofins Scientific,” said Mathieu Floreani, CEO of the SYNLAB Group. “We continue to invest in markets with a higher strategic impact for our Group and adapt our laboratory and service footprint accordingly,” Mathieu continued. “We are very grateful for the commitment and achievements of our colleagues in Spain and are confident that they will further thrive in their new company environment.”

In 2023, the Spanish business contributed approximately €140 million to the Group's revenue. Until the closing of the transaction, which is expected in the first half of 2025, all SYNLAB services in Spain remain in place without any changes.